Body mass index and mortality in men with prostate cancer

Prostate

Volumn 75, Issue 11, 2015, Pages 1129-1136

  Cantarutti, Anna ^a,b   Bonn, Stephanie E ^b   Adami, Hans Olov ^b   Grönberg, Henrik ^b   Bellocco, Rino ^a,b   Bälter, Katarina ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

body mass index; epidemiology; mortality; prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER MORTALITY; CANCER STAGING; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DEATH REGISTRY; DISEASE ASSOCIATION; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SURGERY; REGISTER; RISK ASSESSMENT; BODY MASS INDEX; CASE-CONTROL STUDIES; COMORBIDITY; HUMANS; MIDDLE AGED; OBESITY; PATHOLOGY; PROPORTIONAL HAZARDS MODELS; PROSTATE; PROSTATIC NEOPLASMS; RISK FACTORS; SWEDEN;

AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; COMORBIDITY; HUMANS; MALE; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODELS; PROSTATE; PROSTATIC NEOPLASMS; RISK FACTORS; SWEDEN;

EID: 84932196847     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.23001     Document Type: Article

References (36)

1. OFFICIAL STATISTICS OF SWEDEN, Statistics-Health and Medical Care, www.socialstyrelsen.se, 9 December 2011
2. Gail M, Krickeberg K, Samet J, Tsiatis A, Wong W,. Statistics for Biology and Health. May 1996
3. Rodriquez C, Freedland SJ, Deka A, Jacobs EJ, McCullough ML, Patel AV, Thun MJ, Calle EE,. Body mass index, weight change, and risk of prostate cancer in the cancer prevention study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2007; 16: 63-69.
4. Giovannucci, R., et al., Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 2007; 121: 1571-1578.
5. Stocks, T., et al., Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort. Int J Cancer 2007; 121: 1660-1668.
6. Tindall Elizabeth A, Severi Gianluca, Hoa N Hoang, Southey Melissa C, English Dallas R, Hopper John L, Giles Graham G, Hayes Vanessa M, Australian Prostate Cancer BioResource. Interleukin-6 promoter variants, prostate cancer risk, and survival. The Prostate 2012; 72: 1701-1707.
7. Meyerhard et al., Energetics in colorectal and prostate cancer. J Clin Oncol 2010; 28: 4066-4073.
8. Kathleen EK et al., Time course of risk factors in cancer etiology and progression. J Clin Oncol 2010; 28: 4052-4057.
9. Rodriguez C, Patel AV, Calle EE, et al., Body Mass Index, Height, and Prostate Cancer Mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 2001; 10: 345-353.
10. Giovannucci et al., Pre-diagnostic body-mass index, plasma C-peptide concentration, and prostate cancer specific, ortality in men with prostate cancer: A long-term survival analysis. The Lancet Oncology 2008; 9: 1039-1047.
11. Yin Cao, Jing Ma, Body-mass index, prostate cancer specific mortality and biochemical recurrence: A systematic review and meta-analysis Cancer Prev Res (Phila) 2011; 4; 486-501.
12. SO Andersson, A Wolk, Reinhold Bergström, HO Adami, Engholm Göran, O. Nyrén, Body Size and Prostate Cancer: A 20-Year Follow-up Study among 135 006 Swedish Construction Workers J Nat Cancer Inst 1997; 89 (5): 385-389.
13. Chamberlain C, Romundstand P, Vatten L, Gunnell D, Martin RM., The association of weight gain during adulthood with prostate cancer incidence and survival: A population-based cohort. Int J Cancer 2011; 129: 1199-1206. © 2010 UICC
14. Möller E, Adami HO, Mucci LA, Lundholm C, Bellocco R, Johansson JE, Grönberg H, Bälter K., Lifetime body size and prostate risk in a population-based case-control study in Swden. Cancer Cause AT Control December 2013; 24: 2143-2155.
15. Sierra-Honigmman, M. R., Nath, A. K., Murakami, C., Garcia-Cardena, G., Papapetropulos, A., Sessa, W. C., Madge, L. A., Schechner, J. S., Schwabb, M. B., Polverini, P. J., Flores-Riveros, J. R., Biological action of leptin as an angiogenic factor. Science (Washington DC) 1998; 281: 1683-1686.
16. Fighting Malnutrition Among Cancer Patients. Medical News Today. MediLexicon, Intl., 19 Jul. 2007. Web
17. Morrow GR., Chemotherapy-related nausea and vomiting: Etiology and management. Cancer 1983; 52: 346-352.
18. Wood RM, Lander VL, Mosby EL, Hiatt Wr, Nutrition and the head and neck cancer patient. Oral Surg Oral med Oral Pathol 1989; 68: 391-395.
19. Kokal Wa., The impact of antitumor therapy on nutrition. Cancer 1985; 55: 273-278.
20. Cl. Loprinzi, RM. Goldberg, NL. Burnham, Cancer-associated anorexia and cachexia Drugs 1992; 43: 499-506.
21. Theologides A., Pathogenesis of anorexia and cachexia in cancer. Casncer Bull 1982; 34: 140-149.
22. K. Jennifer Nelson, L. Karen Moxness, D. Michael Jensen, F. Clifford Gastineau., Mayo Clinic Diet Manual (A Handbook of Nutrition Practices) 1994; 12: 261-269.
23. Zheng Lilly S, Sun Jielin, Wiklund Fredrik, Smith Shelly, Stattin Pär, Li Ge, Adami Hans-Olov, Hsu Fang-Chi, Zhu Yi, Bälter Katarina, Kader A Karim, Turner Aubrey R, Liu Wennuan, Bleecker R Eugene, Meyers A Deborah, Duggan David, Carpten D John, Chang Bao-Li, Isaacs B William, Xu Jianfeng, Grönberg Henrik,. Cumulative Association of Five Genetic Variants with Prostate Cancer. N Engl J Med 2008; 358:910-919, February 28, 2008, DOI: 10.1056/NEJMoa075819
24. The Stata Journal (2007). Vol. 7, Number 1, pp. 45-70
25. Kovalchik, S., Validity of adult lifetime self-reported body weight. Public Health Nutr 2009; 12: 1072-1077.
26. Bonn SE, Wiklund F, Sjölander A, Szulkin R., Stattin P, Holmberg E, Grönberg H, Bälter K., Body Mass Index and Weight Change in Men with Prostate Cancer: Progression and Mortality. AT Causes Control 2014; May 9. [Epub ahead of print]
27. Haojie Li, Stampfer Meir J, Mucci Lorelei, Rifai Nader, Qiu Weiliang, Kurth Tobias, Ma Jing,. A 25 year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival. Published online 2009 November 12.
28. Kaaks R, Lukanova A, Sommersberg B., Plasma androgens, IGF-1, body size, and prostate cancer risk: A synthetic review. Prostate Cancer Prostatic Dis 2000; 3: 157-72.
29. Nam SY, Lee EJ, Kim KR, et al., Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 1997; 21: 355-359.
30. Stephen J., Freedland and Elizabeth A. Platz. Obesity and Prostate Cancer: Making Sense out of Apparently Conflicting Data. Epidemiol Rev 2007; 29: 88-97.
31. Haque, et al., 2014. Association of body mass index and prostate cancer mortality. Obes Res Clin Pract. 2014 Jul-Aug; 8: e374-e381.
32. Allott, et al., 2013. Obesity and prostate cancer: Weighing the evidence. Eur Urol 2013;May; 63: 800-809.
33. Discacciati, et al., 2012. Body mass index and incidence of localized and advanced prostate cancer-a dose-response meta-analysis of prospective studies. Ann Oncol 2012 Jul; 23: 1665-1671.
34. World Health Organization, http://apps.who.int/bmi/index.jsp?introPage=intro-3.html
35. C.M Rob, van Kruijsdijk, Elsken van der Wall, L.J. Frank Visseren, Obesity and Cancer: The Role of Dysfunctional Adipose Tissue. Published OnlineFirst September 15, 2009 Cancer Epidemiol Biomarkers Prev October 2009; 18: 2569 10.1158/1055-9965.EPI-09-0372
36. E. Eugenia Calle, Carmen Rodriguez, B.A. Kimberly Walker-Thurmond, J. Michael Thun, Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults N Engl J Med 2003; 348: 1625-1638.